Life Sciences

Track every drug, regulation, and competitor in your space

Parallel reads registries, regulations, filings, and research continuously, returning structured, cited intelligence on every drug, company, and competitor that matters to you.

Start building for freeP[Start building for freeP](https://platform.parallel.ai/)Contact usC[Contact usC](https://contact.parallel.ai/)

Monitor clinical trial registries and FDA updates for my target and indication.

New Phase 2 trial posted for a GLP-1 analog

clinicaltrials.gov

5M AGO

FDA grants Fast Track to a KRAS inhibitor

fda.gov

1H AGO

Competitor reports positive Phase 3 topline

businesswire.com

5H AGO

Trusted by

  • BenevolentAI
  • Formation Bio
  • Convoke
  • BenevolentAI logo
  • Formation Bio logo
  • Convoke logo

Use Cases

Research the whole drug landscape

Map, monitor, and mine the science behind every decision

Map a drug or target's competitive landscape

Give it a therapeutic area, target, or mechanism. Get back approved and investigational assets, the companies behind them, clinical status, and the investors active in the space, as a structured, cited output.

Create a TaskT[Create a TaskT](https://platform.parallel.ai/play)

Map the KRAS G12D inhibitor landscape: assets, the companies behind them, and clinic status.

TASK
#ASSETCOMPANYPHASE
1NVX-301Helix BioPhase 2
2AR-2207Aravon TherapeuticsPhase 1
3BLT-19Beacon Lead TxPreclinical
4SLB-9Solace BioPhase 1

Monitor pipelines, trials, and approvals

Watch the drugs, programs, and competitors you care about: trial readouts, phase transitions, FDA and EMA approvals, guidance, and commercialization events, with alerts the moment something material changes.

Create a MonitorM[Create a MonitorM](https://platform.parallel.ai/play/monitor)

Watch NVX-301 and the KRAS G12D set: trial readouts, phase transitions, and FDA/EMA approvals.

MONITOR

Phase 2 readout, NVX-301 (Helix Bio)

5M AGO

clinicaltrials.gov

Accelerated approval, AR-2207

1H AGO

fda.gov

CHMP positive opinion, BLT-19

5H AGO

ema.europa.eu

Mine scientific literature and clinical data

Pull clean, structured data out of papers, trial registries, and regulatory filings, including efficacy, mechanism of action, endpoints, and real-world evidence.

Try ExtractE[Try ExtractE](https://platform.parallel.ai/play/extract)Create a TaskT[Create a TaskT](https://platform.parallel.ai/play)
CLINICAL DATA

NVX-301 · Phase 2

MECHANISMKRAS G12D inhibitorpubmed.gov
INDICATIONMetastatic colorectal cancerclinicaltrials.gov
ENROLLMENT248clinicaltrials.gov
PRIMARY ENDPOINTORR 41% (95% CI 34–48)clinicaltrials.gov

Discover licensing and M&A targets

Describe your criteria in plain language and get back a live list of assets or companies, including the long tail of private biotechs that never make it onto traditional databases.

Try FindAllF[Try FindAllF](https://platform.parallel.ai/play/find-all)

Private biotechs with a clinical-stage autoimmune asset, founded after 2019, ex-US IP rights unlicensed.

FINDALL
#COMPANYLEAD ASSETPHASEMATCH
1Northwind BioNVX-301Phase 2
2Aravon TherapeuticsARV-118Phase 1
3Solace BioSLB-9Phase 1
4Kestrel BioKST-2Phase 1

Customer Story

Formation Bio runs its drug-development funnel on Parallel

Formation Bio monitors tens of thousands of drug programs daily, auto-enriches the ones that matter, and commissions deep research on priority assets to inform valuation.

Formation Bio logo

Customer Story

Convoke mines the biopharma literature at research-grade precision

The biopharma AI company runs deep research and monitoring over scientific publications, trials, and regulatory sources – Work that demands exact publication dates and traceable citations.

“Parallel provided us with a big upgrade in speed and index coverage. Combined with a 5x improvement in cost efficiency, it was an easy decision to build our agents with them.”
Vikas Velagapudi, Founder, Convoke

“Parallel provided us with a big upgrade in speed and index coverage. Combined with a 5x improvement in cost efficiency, it was an easy decision to build our agents with them.”

Vikas Velagapudi, Founder, Convoke
Convoke logo

Trust

Built for enterprise, secure by design

Every Parallel output includes the Basis framework, unique to Parallel: calibrated confidence scores, citations, source excerpts, and reasoning traces.

  • SOC 2 Type 2
  • Zero data retention Available
  • HIPAA-ready offering
  • GDPR Compliance
  • Single sign-on (SSO/SAML)
  • SOC 2 Type 2
  • Zero data retention Available
  • HIPAA-ready offering
  • GDPR Compliance
  • Single sign-on (SSO/SAML)
PROCESSORS
Per target lookup$0123456789.012345678901234567890123456789

Pay for answers, not tokens

Every Parallel API flexes to fit your needs. Dial speed, depth, and cost to what each workflow is worth, set a budget cap, and hold to it. Per-request pricing means you pay for answers, not tokens, so there’s no incentive to burn context and no surprise bill at the end of the month.

Pricing[Pricing](https://parallel.ai/pricing)

Start building for free

Get started with our APIs in seconds. Run up to 5,000 requests per month for free.

API Playground[API Playground](https://platform.parallel.ai/play)Docs[Docs](https://docs.parallel.ai/getting-started/overview#onboard-your-agent)

Agent onboarding prompt:

Use curl to read parallel.ai/agents.md and perform the setup to install Parallel

Available everywhere you build

  • Google Cloud
  • OpenRouter
  • Vercel
  • LangChain
  • Supabase
  • Google Sheets
  • Snowflake
  • Gemini
  • Hermes Agent
  • OpenClaw
  • n8n
  • MPP

Start building for free

Get started with our APIs in seconds. Run up to 5,000 requests per month for free.

API Playground[API Playground](https://platform.parallel.ai/play)DocsA[Docs](https://docs.parallel.ai/getting-started/overview#onboard-your-agent)
Agent onboarding prompt

Use curl to read parallel.ai/agents.md and perform the setup to install Parallel

ClaudeCodexHermes Agentopencode

Available everywhere you build

Google Cloud logoGoogle Cloud Marketplace

Available everywhere you build

  • OpenRouter logoOpenRouter
  • Vercel logoVercel AI Gateway
  • LangChain logoLangChain
  • Supabase logoSupabase
  • Google Sheets logoGoogle Sheets
  • Snowflake logoSnowflake
  • Gemini logoGemini Enterprise
  • Hermes Agent logoHermes Agent
  • OpenClaw logoOpenClaw
  • n8n logon8n
  • MPP logoMPP
  • OpenRouter
  • Vercel AI Gateway
  • LangChain
  • Supabase
  • Google Sheets
  • Snowflake
  • Gemini Enterprise
  • Hermes Agent
  • OpenClaw
  • n8n
  • MPP

Where agents find answers

Start building for free[Start building for free](https://platform.parallel.ai/)Contact us[Contact us](https://contact.parallel.ai/)

Where agents find answers

Start building for freeP[Start building for freeP](https://platform.parallel.ai/)Contact usC[Contact usC](https://contact.parallel.ai/)
![Company Logo](https://parallel.ai/parallel-logo-540.png)

Contact

  • hello@parallel.ai[hello@parallel.ai](mailto:hello@parallel.ai)

For Content Owners

  • index.parallel.ai[index.parallel.ai](https://index.parallel.ai)

Products

  • Task API[Task API](https://parallel.ai/products/task)
  • Monitor API[Monitor API](https://parallel.ai/products/monitor)
  • FindAll API[FindAll API](https://parallel.ai/products/findall)
  • Chat API[Chat API](https://parallel.ai/products/chat)
  • Search API[Search API](https://parallel.ai/products/search)
  • Extract API[Extract API](https://parallel.ai/products/extract)
  • Index by Parallel[Index by Parallel](https://index.parallel.ai)

Solutions

  • Sales[Sales](https://parallel.ai/solutions/sales-marketing)
  • Finance[Finance](https://parallel.ai/solutions/finance)
  • Legal[Legal](https://parallel.ai/solutions/legal)
  • Coding & Building[Coding & Building](https://parallel.ai/solutions/code)
  • Life Sciences[Life Sciences](https://parallel.ai/solutions/life-sciences)
  • Insurance[Insurance](https://parallel.ai/solutions/insurance)
  • Productivity[Productivity](https://parallel.ai/solutions/productivity)

Developers

  • Docs[Docs](https://docs.parallel.ai/getting-started/overview)
  • Onboard your Agent[Onboard your Agent](https://docs.parallel.ai/getting-started/overview#onboard-your-agent)
  • Parallel MCP[Parallel MCP](https://docs.parallel.ai/integrations/mcp/quickstart)
  • Parallel CLI[Parallel CLI](https://docs.parallel.ai/integrations/cli)
  • API Reference[API Reference](https://docs.parallel.ai/api-reference)
  • Python SDK[Python SDK](https://pypi.org/project/parallel-web/)
  • Typescript SDK[Typescript SDK](https://www.npmjs.com/package/parallel-web)
  • Integrations[Integrations](https://docs.parallel.ai/integrations/agentic-payments)
  • Changelog[Changelog](https://docs.parallel.ai/resources/changelog)
  • Status[Status](https://status.parallel.ai/)
  • Support[Support](mailto:support@parallel.ai)

Company

  • About[About](https://parallel.ai/about)
  • Press[Press](https://parallel.ai/press)
  • Careers[Careers](https://parallel.ai/careers)
  • Pioneers[Pioneers](https://pioneers.parallel.ai/)
  • Museum of the Human Web[Museum of the Human Web](https://museum.parallel.ai/)

Resources

  • Blog[Blog](https://parallel.ai/blog)
  • Benchmarks[Benchmarks](https://parallel.ai/benchmarks)
  • Become a Content Partner[Become a Content Partner](https://index.parallel.ai/join)
  • Pricing[Pricing](https://parallel.ai/pricing)

Legal

  • Terms of Service[Terms of Service](https://parallel.ai/terms-of-service)
  • Customer Terms[Customer Terms](https://parallel.ai/customer-terms)
  • Privacy[Privacy](https://parallel.ai/privacy-policy)
  • Acceptable Use[Acceptable Use](https://parallel.ai/acceptable-use-policy)
  • Bots[Bots](https://parallel.ai/parallel-web-systems-bots)
  • Trust Center[Trust Center](https://trust.parallel.ai/)
  • Report Security Issue[Report Security Issue](mailto:security@parallel.ai)
LinkedIn[LinkedIn](https://www.linkedin.com/company/parallel-web/about/)Twitter[Twitter](https://x.com/p0)GitHub[GitHub](https://github.com/parallel-web)YouTube[YouTube](https://www.youtube.com/@parallelwebsystems)Events[Events](https://luma.com/parallelwebsystems)
All Systems Operational
![SOC 2 Compliant](https://parallel.ai/soc2.svg)

Parallel Web Systems Inc. 2026